Clinical trial
An Observational Cohort Study of the Use of Avatrombopag in Patients With Thrombocytopenia Associated With Chronic Liver Disease Undergoing a Procedure
NCT03554759 is registered in ClinicalTrials.gov with Sobi, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Cohort Study of the Use of Avatrombopag in Patients With Thrombocytopenia Associated With Chronic Liver Disease Undergoing a Procedure
- Lead sponsor
- Sobi, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- July 2, 2018
- Completion date
- January 31, 2019
- Enrollment
- 50 (actual)
- Sites
- 41
Conditions
As the registry lists them; a condition with its own page is linked.